Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis

American Journal of Gastroenterology

Volumn 93, Issue 12, 1998, Pages 2397-2404

  Guimbaud, Rosine ^a   Bertrand, Viviane ^a   Chauvelot Moachon, Laurence ^a   Quartier, Gilles ^a   Vidon, Nicole ^a   Giroud, Jean Paul ^a   Couturier, Daniel ^a   Chaussade, Stanislas ^a  

^a Hopital Cochin et Univ Rene D ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HUMAN; INTESTINE PERFUSION; MALE; PRIORITY JOURNAL; SCINTIGRAPHY; THROMBOCYTE COUNT; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLON; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MULTIVARIATE ANALYSIS; PERFUSION; PEROXIDASE;

EID: 0032417085     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00694.x     Document Type: Article

References (32)

1. 1. Baggiolin M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines; CXC and CC chemokines. Adv Immunol 1994;55: 97-179.
2. 2. Akira S, Hirano T, Taga T, et al. Biology of multifunctional cytokines: IL6 and relaxed molecules (IL1 and TNF). FASEB J 1990;4:2860-7.
3. 3. Mosmann T, Sad S. The expanding universe of T-cell subsets Th1, Th2 and more. Immunol Today 1996;17:138-46.
4. 4. Isaacs K, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
5. 5. Maclam MZ, Hodgson HJF. Interrelations between interleukin 6, interleukin 1β, plasma C-reactive protein values, and in vitro C reactive protein generation in patients with inflammatory bowel disease. Gut 1994;35:77-83.
6. 6. Stevens C, Walz G, Singararn C, et al. Tumor necrosis factor α, interleukin β, and interleukin 6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
7. 7. Raab Y, Gerdin B, Ahlsted S, et al. Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 1993;34:1203-6.
8. 8. Raab Y, Hallgren R, Gerdin B. Enhanced intestinal synthesis of interleukin-6 is related to the disease severity and activity in ulcerative colitis. Digestion 1994;55:44-9.
9. 9. Guimbaud R, Izzo A, Martinolle P, et al. Intraluminal excretion of Paf, lysopaf and acetylhydrolase in patients with ulcerative colitis. Dig Dis Sci 1995;40:2635-40.
10. 10. Collawn C, Rubin P, Perez N, et al. Phase II study of the safety and efficacy of 5-lipoxygenase inhibitor in patients with ulcerative colitis. Am J Gastroenterol 1992;87:342-6.
11. 11. Lantto E, Jarvi K, Krekela I, et al. Technetium-99m hexamethyl propylene amine oxime leucocytes in the assessment of disease activity in inflammatory bowel disease. Eur J Nucl Med 1992;19:14-8.
12. 12. Bradley P, Priebat D, Christensen R, et al. Measurement of cutaneous inflammation; estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
13. 13. Smith J, Castro G. Relation of peroxydase activity in gut mucosa to inflammation. Am J Physiol 1978;234:R72-9.
14. 14. Baggarwal B, Natarajan K. Tumor necrosis factors: Developments during the last decade. Eur Cyt Network 1996;7:93-124.
15. 15. Dirarello C. The biological properties of interleukin-1. Eur Cyt Network 1994;5:517-31.
16. 16. Eckmann L, Jung H, Schürer-Maly C, et al. Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin 8. Gastroenterology 1993;105:1689-1997.
17. 17. Graham M, Willey A, Adams J, et al. Interleukin 1β down regulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology 1996;110:344-50.
18. 18. Brynskov J, Tvede N, Andersen C, et al. Increased concentrations of interleulin 1β interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992;33:55-8.
19. 19. Casini-Raggi V, Kam L, Chong Y, et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. Gastroenterology 1995; 154:2434-40.
20. 20. Youngman K, Simon P, West G, et al. Localization of interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993;104:749-58.
21. 21. Dieleman L, Elson C, Tennyson G, et al. Kinetics of cytokine expression during healing of acute colitis in mice. Am J Physiol 1996;271: G130-6.
22. 22. McAlindon M, Hawkey C, Mahida Y. Interleukin-1β converting enzyme (ICE) is expressed by macrophages in the lamina propria of active inflammatory bowel disease (IBD) mucosa. Gut 1996;39:A93.
23. 23. Mitsuyama K, Toyonaga A, Sasaki E, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994;96:432-5.
24. 24. Sartor RI. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994;106:553-9.
25. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFNγ, whereas ulcerative-colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-70.
26. 26. McDonald T, Murch S. Aetiology and pathogeneis of chronic inflammatory bowel disease. Baillièr's Clin Gastroenterol 1994;8:1-34.
27. 27. Mullin G, Lazenby A, Harris M, et al. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992;102:1620-7.
28. 28. Hollen C, Henthorn J, Kozio J, et al. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 1991; 79:286-90.
29. 29. Tomer A, Regulation de la thrombopoīèse. Triangle 1994;XXXIV 3:125-36.
30. 30. Yams J, Fitzgerald J, Treem W, et al. Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology 1993;104:1285-92.
31. 31. Collins C, Cahill M, Newland A, et al. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106:840-5.
32. 32. Schaufelberger HD, Uhr M, McGuckin C, et al. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur J Clin Invest 1994;24:656-63.